Issue Date	Title	Author(s)
31-Aug-2018	Cardiovascular adverse events in modern myeloma therapy - incidence and risks. A review from European Myeloma Network (EMN) and Italian Society of Arterial Hypertension (SIIA)	Bringhen, S; Milan, A; Ferri, C; Wäsch, R; Gay, F, et al
15-Jul-2024	Cardiovascular events in CML patients treated with nilotinib: validation of the HFA-ICOS baseline risk score	Fernando, F; Andres, MS; Claudiani, S; Kermani, NZ; Ceccarelli, G, et al
10-Sep-2020	Cardiovascular risk assessment using ultrasonographic surrogate markers of atherosclerosis and arterial stiffness in patients with chronic renal impairment: a narrative review of the evidence and a critical view of their utility in clinical practice	Kousios, A; Kouis, P; Hadjivasilis, A; Panayiotou, A
1-Oct-2021	Carfilzomib or bortezomib in combination with cyclophosphamide and dexamethasone followed by carfilzomib maintenance for patients with multiple myeloma after one prior therapy: results from a multi-centre, phase II, randomized, controlled trial (MUKfive)	Yong, KL; Hinsley, S; Auner, HW; Bygrave, C; Kaiser, MF, et al
27-Oct-2014	CD28 expression is required after T cell priming for helper T cell responses and protective immunity to infection	Linterman, MA; Denton, AE; Divekar, DP; Zvetkova, I; Kane, L, et al
23-Apr-2020	CD28 fusions: an opportunity for young ATL?	Cook, LBM; Rowan, AG
15-Nov-2022	CD8(+) TEMRA clones cause platelet lysis in immune thrombocytopenia	Malik, A; Tan, MMH; Sayed, AA; Han, P; Watt, E, et al
1-Nov-2018	CD93 regulates CNS inflammation in two mouse models of autoimmune encephalomyelitis	Griffiths, MR; Botto, M; Morgan, BP; Neal, JW; Gasque, P
9-Mar-2020	Cellular memory enhances bacterial chemotactic navigation in rugged environments	Gosztolai, A; Barahona, M;
12-Mar-2018	Changes in macrophage transcriptome associate with systemic sclerosis and mediate GSDMA contribution to disease risk	Moreno-Moral, A; Bagnati, M; Koturan, S; Ko, J-H; Fonseca, C, et al
9-Nov-2020	Characterisation of a novel thrombomodulin c.1487delC,p.(Pro496Argfs*10) variant and evaluation of therapeutic strategies to manage the rare bleeding phenotype.	Morrow, GB; Beavis, J; Harper, S; Bignell, P; Laffan, MA, et al
1-Oct-2021	Characterisation of an enhanced preclinical model of experimental MPO-ANCA autoimmune vasculitis	Prendecki, M; Gulati, K; Turner-Stokes, T; Bhangal, G; Chiappo, D, et al
21-May-2021	Chlamydia trachomatis: cell biology, immunology and vaccination	McKay, P; Murray, S
11-May-2021	Chromatin accessibility governs the differential response of cancer and T cells to arginine starvation	Crump, NT; Hadjinicolaou, A; Xia, M; Walsby-Tickle, J; Gileadi, U, et al
14-Sep-2021	Chromatin-based, in cis and in trans regulatory rewiring underpins distinct oncogenic transcriptomes in multiple myeloma	Karadimitris, A
Mar-2024	Chronic abdominal aortic occlusive disease related to antiphospholipid syndrome: a rare presentation	Jiang, H; Shi, Y; Liu, W; Liu, B; Chen, Y-X, et al
28-Jan-2022	Chronic kidney disease mediates cardiac dysfunction associated with increased resident cardiac macrophages	Woollard, K
30-Jun-2017	Circulating complement factor H-related proteins 1 and 5 correlate with disease activity in IgA nephropathy	Medjeral-Thomas, NR; Lomax-Browne, HJ; Beckwith, H; Willicombe, M; McLean, AG, et al
7-Aug-2020	Circulating FH protects kidneys from tubular injury during systemic hemolysis	Merle, NS; Leon, J; Poillerat, V; Grunenwald, A; Boudhabhay, I, et al
Jun-2024	Circulating micromegakaryocytes in an asplenic patient with post-polycythemia myelofibrosis	Borg, A; Ballon, V; Bain, BJ